Clinical trials of immunotherapy in triple-negative breast cancer

PURPOSE: Immunotherapy has started to transform the treatment of triple-negative breast cancer (TNBC), in part due to the unique immunogenicity of this breast cancer subtype. This review summarizes clinical studies of immunotherapy in advanced and early-stage TNBC. FINDINGS: Initial studies of check...

Descripción completa

Detalles Bibliográficos
Autores principales: Howard, Frederick M., Pearson, Alexander T., Nanda, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338129/
https://www.ncbi.nlm.nih.gov/pubmed/35834065
http://dx.doi.org/10.1007/s10549-022-06665-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338129/
https://www.ncbi.nlm.nih.gov/pubmed/35834065
http://dx.doi.org/10.1007/s10549-022-06665-6

Ejemplares similares